Molecular and functional characterization of allogantigen-specific anergic T cells suitable for cell therapy. - Wikidata - wikimedia - TriplyDB

Molecular and functional characterization of allogantigen-specific anergic T cells suitable for cell therapy.

Molecular and functional characterization of allogantigen-specific anergic T cells suitable for cell therapy.

http://www.wikidata.org/entity/Q41325733

about

Clinical Outlook for Type-1 and FOXP3(+) T Regulatory Cell-Based Therapy Regulatory T cells and their roles in immune dysregulation and allergy.In vitro HIV infection impairs the capacity of myeloid dendritic cells to induce regulatory T cells.HLA Class Ib Molecules and Immune Cells in Pregnancy and Preeclampsia The Role of Dendritic Cell Subsets and Innate Immunity in the Pathogenesis of Type 1 Diabetes and Other Autoimmune Diseases.Enforced IL-10 expression confers type 1 regulatory T cell (Tr1) phenotype and function to human CD4(+) T cells.Regulatory T Cell Immunotherapy in Immune-Mediated Diseases Immunological Outcome in Haploidentical-HSC Transplanted Patients Treated with IL-10-Anergized Donor T Cells Dendritic cells in networks of immunological tolerance.Clinical tolerance in allogeneic hematopoietic stem cell transplantation.Moving to tolerance: clinical application of T regulatory cells Clinical perspectives for regulatory T cells in transplantation tolerance.The cellular and molecular mechanisms of immuno-suppression by human type 1 regulatory T cells.Human tolerogenic DC-10: perspectives for clinical applications.Potential and limitations of regulatory T-cell therapy in solid organ transplantation.New insights into HLA-G mediated tolerance.Strategies to accelerate immune recovery after allogeneic hematopoietic stem cell transplantation.Regulatory T cell-based therapies for autoimmunity.Generation of donor-specific Tr1 cells to be used after kidney transplantation and definition of the timing of their in vivo infusion in the presence of immunosuppression.IL-10 Receptor Signaling Is Essential for TR1 Cell Function In Vivo.IL-10-Engineered Human CD4(+) Tr1 Cells Eliminate Myeloid Leukemia in an HLA Class I-Dependent Mechanism.HLA-G expression levels influence the tolerogenic activity of human DC-10.Engineered T Regulatory Type 1 Cells for Clinical Application.[Use of regulatory T cells in cellular therapies in autoimmune diseases].Interleukin-10-Producing DC-10 Is a Unique Tool to Promote Tolerance Via Antigen-Specific T Regulatory Type 1 Cells.APVO210: A Bispecific Anti-CD86-IL-10 Fusion Protein (ADAPTIR™) to Induce Antigen-Specific T Regulatory Type 1 Cells.

P2860

Q26774657-C8A4226C-6CDD-414F-A873-3BB05EBC1849 Q34166571-BFFE8CE6-A0E5-428B-B7E4-9833D4B0CEB1 Q34388925-127A1D74-9E5E-49FE-A797-36C19F2ABC62 Q34763454-6A85AF96-D5F4-41FF-82B6-200A66BE3982 Q35739662-43757A23-96EB-4DED-BA9F-C6D3A3051C9C Q36220670-610A14DF-B9B2-4F88-9374-AEB271D413FF Q36462109-D273C31F-F097-432C-8773-8505668226DA Q37535106-7A4B29D4-50C1-4496-9AF1-6F9E02553DF1 Q37826763-6043214E-3A3B-4726-9CF1-C07689AD3F3D Q37864697-6459C808-1B42-441A-9E9C-7AB39171C1F2 Q37881151-8FE9484C-3B57-4B9C-AEDE-C14EB1F441AB Q37912653-AA84DDB4-4DF9-451C-95A3-230EBF3453A0 Q38008355-2B3D4A4E-D47E-436A-8C27-3F22BD74E177 Q38078109-A835A88C-06E7-4602-97FA-AC6E0A5DDD75 Q38235166-BE3F037B-92F0-44E5-9EAD-E340EB9AC917 Q38240763-F4ABD51D-EC8D-4D05-B7D2-D2F2A611C90E Q38640239-A47623F0-10B0-4E37-9FD7-4720FFB6C022 Q38943933-BFAEF966-61C7-411B-B386-93F94F2A4723 Q38949736-D8B17240-3337-4C2B-A861-0CEFA57FF022 Q39076791-A13C310E-BBA2-40DF-9961-CEF1E80870BE Q40093839-5BF12AB2-557C-4CB0-82CB-79EB75D8E024 Q41465101-8B7EF828-7877-487A-B2F7-797C997932F3 Q52678018-CB166374-FCC1-46BA-A8A8-CE5E3F47174C Q54492304-2E83E619-8ECA-45D4-AF3D-F8FC93600B72 Q55013923-68EB5DC9-8571-40E3-B643-ED0498205541 Q55260575-5C444779-BAFB-4237-8E2B-84D5E60D9E3B

P2860

Molecular and functional characterization of allogantigen-specific anergic T cells suitable for cell therapy.

http://www.wikidata.org/entity/Q41325733

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Molecular and functional chara ...... lls suitable for cell therapy.

@en

type

label

Molecular and functional chara ...... lls suitable for cell therapy.

@en

prefLabel

Molecular and functional chara ...... lls suitable for cell therapy.

@en

P1433

Q41325733-15ADA8A8-10CF-4B78-90FC-328B22DF7E66

P1476

Q41325733-A997D373-C898-48E8-9EE8-BA849714682C

P2093

Q41325733-12ECDECB-6685-4E54-AD16-CCCEEAF4B5A0

Q41325733-139B9F0A-4485-4B63-B7D8-388F1B46453B

Q41325733-176D9526-B140-4800-8B9A-F8A948EA45BD

Q41325733-46A38BA0-E48B-4B55-A8B6-FDBB504A7B47

Q41325733-A64AD045-9F62-4D28-A1C2-F7098CB3F40A

Q41325733-B51C1B99-A9BF-4906-BB16-8C91227AD431

Q41325733-B86793E1-1A4B-4911-8B1B-4E9AB96C0027

Q41325733-C1B6537D-945E-4989-A293-B38BC9A7301F

Q41325733-DB0163F5-1079-4533-942D-AEE65421C781

Q41325733-EF8F5BC8-0D10-47AA-AD88-A81A2FAAD688

P2860

Q41325733-08B24577-2F18-401E-84E6-1435FBFC8C16

Q41325733-26F27FD0-3B36-4D42-BB56-A4992F09DEF0

Q41325733-2C7D25C2-F33A-4850-934B-5D8C448D5F7E

Q41325733-452D1871-167E-4F9F-B845-A311AB6660D8

Q41325733-48D4088D-233A-40DD-8F4B-F46083F0D02B

Q41325733-58877ECF-B45F-4EB2-B3A3-E080D59C5BF6

Q41325733-5D716AC2-BEAA-4313-99E4-98D12893A7AC

Q41325733-7D05D5E6-AA47-4339-84B4-6995AEE444D6

Q41325733-87103849-99E0-487A-9E72-A2CB87D8ED77

Q41325733-968BD901-0FCF-435B-AE8F-6B9DA4CC608C

P304

Q41325733-4395D093-C059-465A-8088-D6EEFD40C692

P31

Q41325733-DFA76D7F-D93E-4D3D-BD31-234DC0D0A2F7

P356

Q41325733-EA25F4D1-8AB8-4099-A285-B9A21AEC2728

P433

Q41325733-1117C0AE-3514-4FE6-B91F-173685F0DDA0

P478

Q41325733-E7CBB845-18BF-478F-86EE-A7C7C80EB648

P50

Q41325733-4B899A02-AD50-4E43-8D65-15D0C9A75E80

Q41325733-A28A8462-4590-4961-873E-5D31B1B4B3CF

P577

Q41325733-641E6D56-2BE8-45DF-9E2F-8B6129A4B033

P5875

Q41325733-A7FD5F01-E09E-45FD-8EE3-AE4BFD6C7FFE

P698

Q41325733-8790A773-2326-4BC0-B4DE-B8F0DDC20600

P932

Q41325733-E6D62947-BED7-46C3-B901-9917E58CD73E

P356

HAEMATOL.2010.025825

P1433

P1476

Molecular and functional chara ...... ells suitable for cell therapy

@en

P2093

Carlo Terenzio Paties

http://www.w3.org/2001/XMLSchema#string

Claudia Sartirana

http://www.w3.org/2001/XMLSchema#string

Elisabetta Zino

http://www.w3.org/2001/XMLSchema#string

Giorgia Serafini

http://www.w3.org/2001/XMLSchema#string

Katharina Fleischhauer

http://www.w3.org/2001/XMLSchema#string

Maurilio Ponzoni

http://www.w3.org/2001/XMLSchema#string

Rosa Bacchetta

http://www.w3.org/2001/XMLSchema#string

Stefan Tomiuk

http://www.w3.org/2001/XMLSchema#string

Ute Schulz

http://www.w3.org/2001/XMLSchema#string

Uwe Jansen

http://www.w3.org/2001/XMLSchema#string

P2860

Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway

Interleukin-10: new perspectives on an old cytokine

Gene Expression Omnibus: NCBI gene expression and hybridization array data repository

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

Altered T-cell receptor + CD28-mediated signaling and blocked cell cycle progression in interleukin 10 and transforming growth factor-beta-treated alloreactive T cells that do not induce graft-versus-host disease.

A genomic approach to human autoimmune diseases.

Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans.

Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.

A cytoskeleton-associated protein, TMAP/CKAP2, is involved in the proliferation of human foreskin fibroblasts.

Interleukin-10-secreting type 1 regulatory T cells in rodents and humans.

P304

2134-2143

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.2010.025825

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P50

Maria Grazia Roncarolo

P577

2010-08-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45659771

http://www.w3.org/2001/XMLSchema#string

P698

20713457

http://www.w3.org/2001/XMLSchema#string

P932

2995573

http://www.w3.org/2001/XMLSchema#string